MISSION
Panakes is a venture capital firm with the ultimate goal of providing a better life to people all around the world.
We back promising teams by providing both financial and business support to build the next generation of game-changing technologies companies in the field of Life Sciences.
We invest in ambitious early stage start-ups and SMEs with innovative products globally, mainly across Europe and Israel.
We bring strong entrepreneurial and financial expertise to portfolio companies well beyond just capital, relying on a wide network of clinicians and industry experts. We have established relationships with selected industrial partners to assist our founders in accelerating their development.
We invest in people, believing that a strong and dedicated team is one of the most important factors in the success of our investments. We aim to work together with entrepreneurs to develop successful businesses as an active and well-connected investor.
We invest for people, supporting the growth of companies and people that will reshape the medical world, answering real medical needs, saving lives and providing a better quality of life for patients and care-givers.
An overall positive impact that will produce intrinsic value for both investors and society.
TEAM
ADVISORS

SERGIO ABRIGNANI
Scientific Director INGM (Istituto Nazionale di Genetica Molecolare)
ANTONELLO BISCINI
Former VP BizDev Diagnostic Menarini Group

PAOLA CASTAGNOLI
Scientific Director Fondazione Toscana Life Sciences
FABRIZIO CHINES
Executive Chairman & CEO SIFI
VALENTINA COGLIATI
CEO Elemaster
MAURIZIO COLOMBO
Owner & Executive VP Sapiolife
EMANUELE GATTI
Former CEO EMEA Fresenius Medical Care
MASSIMO MERCATI
CEO Aboca
FABIO PAMMOLLI
Analytics & Data Scientist, Professor Politecnico di Milano
SIMONE RE
CEO Digitec Innovation
LUCIO ROVATI
CEO & Chairman Rottapharm
RAFFAELE VENAFRO
Founder CrossmedPORTFOLIO
NEWS

Pisa - Italy, July 20, 2022
Medical Microinstruments Secures $75M to Advance Robotic Microsurgery

Milan - Italy, July 19, 2022
BetaGlue Technologies: closing of a EUR 10 million financing round

Galway - Ireland, May 17, 2022
Vivasure Medical Announces Series D Financing to Advance Portfolio of PerQseal Vessel Closure Devices